This presentation reviews critical elements of diagnosis, important considerations in pharmacotherapy, and utilizes a case study approach to analyze the best treatment regimens. | 1.50 credits (1.50 pharmacology) | $45

This presentation reviews the pathophysiology of ADD as the target of pharmacotherapy. Pharmacotherapeutics of psychostimulants, norepinephrine reuptake inhibitors, antiadrenergic agonists, and wakefulness agents are analyzed, with emphasis on indications and efficacies for each. Case studies are then used to evaluate best-practice options in a variety of clinical scenarios including pediatric, adult and psychostimulants contraindicated. | 1.50 credits (1.50 pharmacology) | $45.00

The focus of this program is the analysis and application of appropriate pharmacotherapy for the treatment of bipolar depression, bipolar mania, cyclothymia, and prevention of relapse. Drug selection, indications, and important safety issues are analyzed in a case study presentation. | 1.50 credits (1.50 pharmacology) | $45.00

This program presents the physiology of anxiety disorders as a foundation for pharmacologic management, key features in differentiating among anxiety disorders, and pharmacologic choices for acute and chronic management. | 1.50 credits (1.50 pharmacology) | $45.00

This program begins with a brief review of differentiating mood disorders from unipolar depression. Relevant physiologic pathways as a target of pharmacotherapy are presented. The focus of this program is analysis and application of appropriate pharmacotherapy for the treatment of bipolar depression, bipolar mania, cyclothymia and prevention of relapse. Drug selection, indications, and important safety issues are analyzed in the case study presentation. | 1.50 credits (1.50 pharmacology) | $45

This presentation reviews the physiology of the CYP450 metabolic cascade and its function in preparing drugs for excretion. Based upon a foundation of physiology, the day-to-day implications of safe prescribing are presented with case study illustrations and analysis. | 1.50 credits (1.50 pharmacology) | $45

This presentation focuses on drug therapy as the etiology of symptoms. Sometimes the etiology of the chief complaint is a mystery, and ultimately turns out that presenting symptoms are the results of medications the patient is taking; sometimes prescribed, over the counter, or “borrowed from a friend.” This presentation highlights case studies in which drugs were ultimately identified as the etiology. | 1.50 credits (1.50 pharmacology) | $45

The overwhelming majority of psychotropic medications are prescribed in the primary care setting. The presentation reviews a series of case studies from the primary care setting with subtle indicators of the correct diagnosis which will best direct pharmacotherapy. | 1.50 credits (1.50 pharmacology) | $45

This program analyzes current drug classes used for the treatment of blood cholesterol as necessary to optimize atherosclerotic cardiovascular risk. Current American College of Cardiology/American Heart Association recommendations are evaluated in the context of implementing appropriate drug treatment strategies. Case study application is utilized to compare and contrast available drug classes and prioritize their use from a risk/benefit perspective. Case study application is used to illustrate best practices. | 1.5 credits (1.5 pharmacology) | $45

This presentation emphasizes pharmacologic management of mood disorders across the mood spectrum. Using case studies from both primary care and the mental health care settings, managing the plan of care is analyzed using mood stabilizer, antipsychotic, and antidepressant therapies to achieve best patient outcomes. Differentiating among medications in the same class as well as utilization of best combination therapies is discussed. | 1.5 credits (1.5 pharmacology) | $45